Investing.com - iRhythm Tech (NASDAQ: IRTC) reported first quarter EPS of $-1.23, $0.25 worse than the analyst estimate of $-0.98. Revenue for the quarter came in at $131.93M versus the consensus estimate of $128.41M.
Guidance
iRhythm Tech sees FY 2024 revenue of $578.00M-$588.00M versus the analyst consensus of $580.80M.
iRhythm Tech's stock price closed at $110.88. It is down -7.52% in the last 3 months and down -16.64% in the last 12 months.
iRhythm Tech saw 0 positive EPS revisions and 5 negative EPS revisions in the last 90 days. See iRhythm Tech's stock price’s past reactions to earnings here.
According to InvestingPro, iRhythm Tech's Financial Health score is "fair performance".
Check out iRhythm Tech's recent earnings performance, and iRhythm Tech's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar